Intracellular expression of human immunodeficiency virus type 1 (HIV-1) protease variants inhibits replication of wild-type and protease inhibitor-resistant HIV-1 strains in human T-cell lines.
Full text
Figure
Related documents
Reduction of HIV-1 infectivity by CsA or the G89V mutant is independent of TRIM5 ␣hu in human T cells?. CEM-SS cells were transduced with an HIV-based vector delivering an
We have constructed a human immunodeficiency virus type 1 (HIV-1)-based lentiviral vector expressing a 937-base antisense sequence against the HIV-1 envelope gene.. Transduction of
SHORT REPORT Open Access Human Phosphate Binding Protein inhibits HIV 1 gene transcription and replication Thomas Cherrier1,2,6?, Mikael Elias7?, Alicia Jeudy1, Guillaume
Treatment of human immunodeficiency virus type 1 (HIV-1)-infected CEM cell cultures with escalating concentrations of the quinoxaline S-2720 resulted in an ordered appearance of
To investigate whether Vif influences the activity of HIV-1 protease (PR), the viral enzyme which is responsible for processing Gag and Gag-Pol precursor polyproteins into mature
BILA 1906 BS and BILA 2185 BS are substrate analog protease inhibitors that have potent antiviral activity with lim- ited cytotoxicity (7). With these inhibitors, highly resistant
The human immunodeficiency virus type 1 (HIV-1) protease is the enzyme required for processing of the Gag and Gag-Pol polyproteins to yield mature, infectious virions.. Although
(a) Immunoprecipitation by a human HIV-positive serum of Env proteins expressed in BHK-21 cells coinfected with recombinant VVTG9-1 expressing the native Env protein of HIV-lBRU and
